Mission Impossible: Impossibility Preemption Post-Levine

Law360, New York (May 8, 2012, 1:29 PM EDT) -- In Wyeth v. Levine[1], the U.S. Supreme Court held that the standard for finding impossibility preemption was whether “clear evidence” existed that the U.S. Food and Drug Administration (FDA) would have rejected the label change required by state law, thus making it impossible for the manufacturer to comply with both state and federal requirements.

In doing so, the court created more questions than answers.

The court did not define exactly what constitutes “clear evidence,” and since then it has been seemingly impossible for drug manufacturers to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.